What is Alport syndrome?

Jan 13, 2025 ... ... kidney diseases; U.S. commercial launch planned in 2H 2025, if approved. Initiation of two Phase 3 studies planned for 2H 2025, one in focal ... Not an actual patient. FILSPARI is proven to powerfully lower proteinuria and preserve kidney function by working directly in the kidneys ... Individuals over age 65 or who have pre-existing kidney disease may be at an increased risk of adverse kidney effects. Blood clots causing stroke, heart ... Foodborne illnesses are caused by consuming contaminated foods or beverages. Many different disease-causing microbes, or pathogens, can contaminate foods, so ... Submission formats are defined for each type of health plan (e.g., commercial, Medicare, Medicaid) and data provider group. Schedules for data submission, ... Jun 16, 2010 ... This information was merged with data in the United States Renal Data System to determine all-cause and cardiovascular mortality. Patients ... Eligible patients must have commercial insurance coverage for TRUXIMA. Uninsured and cash-paying patients are NOT eligible for the Program nor are patients with ... Sep 22, 2023 ... Sudden worsening of kidney function has happened in people who are taking JARDIANCE. You may be at a higher risk of dehydration if you: take ... May 14, 2024 ... ... causes of kidney failure in young adults in China. Among IgAN patients, the risk of progressing to end-stage renal disease in Asian ... Information about commercial tobacco product use on the health of the U.S. and on individuals ... Get information on the impact of diseases caused by smoking, ...